PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-188.64%
Negative net income growth while CNQ stands at 273.62%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
11.84%
Some yoy growth while CNQ is negative at -355.56%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-15.09%
Both cut yoy SBC, with CNQ at -43.24%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-53.33%
Both reduce yoy usage, with CNQ at -2164.29%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-342.86%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-53.33%
Both reduce yoy usage, with CNQ at -2164.29%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-24.19%
Negative yoy while CNQ is 2.78%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.99%
Operating cash flow growth below 50% of CNQ's 39.60%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-72.20%
Negative yoy CapEx while CNQ is 39.60%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-99.23%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
1080.00%
Purchases growth of 1080.00% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
72.20%
Liquidation growth of 72.20% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-47.32%
Both yoy lines negative, with CNQ at -48.06%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-129.52%
We reduce yoy invests while CNQ stands at 37.57%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
98.87%
We repay more while CNQ is negative at -153.05%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-84.91%
Negative yoy issuance while CNQ is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.